| 生物活性 | Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is an IgG1 antibody inhibitor targeting VEGFR-1/FLT1 with antitumor activity that blocks ligand-dependent phosphorylation and downstream signaling, reduces MAPK and Akt activity in breast cancer xenograft models, inhibits the proliferation and invasion of VEGFR-1-positive tumor cells, and reverses the conversion of M1 macrophages to a pro-tumor M2-like phenotype; it also inhibits tumor cell proliferation, promotes apoptosis, and effectively suppresses tumor growth through direct targeting of tumor and host-supporting mechanisms, and in addition, Icrucumab exhibits synergistic effects when combined with chemotherapeutic agents and has been used in studies on various cancers including advanced solid malignancies, thyroid cancer, melanoma, and lung cancer. |
| IC50 & Target | VEGFR1/FLT1 |
| 体外研究 (In Vitro) |
Icrucumab (30 μg/mL) 通过抑制 FLT-1 (VEGFR-1) 减轻 Dexamethasone (MS-E10819) 介导的 M1 巨噬细胞向 M2 样表型转化,增加 M1 标志物表达并降低 M2 标志物表达,进而调控肿瘤相关巨噬细胞极化,间接影响肿瘤进展。 |
| 性状 | 液体 |
| 颜色 | Colorless to light yellow |
| CAS No. | 1024603-92-6 |
| 别名 | 艾芦库单抗; Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
| 运输条件 | Shipping with dry ice. |
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。